ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Aster DM Quality Care Earnings Call: Key Takeaways

Aster DM Healthcare reported Q4FY26 revenue of ₹1,182 Cr (up 18%) and Operating EBITDA of ₹244 Cr (up 26%). Strategy focuses on merger with QCIL and major bed capacity expansion.

Highlights
Revenue growth18% YoY for Q4FY26 (India Overall)
MarginsOperating EBITDA margins improved to 21.9% (combined proforma)
Demand visibilityHigh; 1.93 Mn patient volume in Q4 (12% growth)
Management confidenceStrong; overwhelming shareholder approval (96.68%) for merger

Growth

Combined proforma FY26 revenue grew 14% to ₹9,273 Cr; EBITDA grew 21% to ₹2,013 Cr.

Outlook

Planned addition of 4,445 beds to reach 15,068 total capacity. Merger completion expected in Q1 FY27.

Risks

Minor temporary impact from nurses' strike in Kerala and macro headwinds noted in clinical/lab segments.

Source

Earnings Call filed with BSE, NSE: ASTERDM. Summary written with AI assistance from the document.

Read the document ↗

Aster DM Quality Care Ltd: key numbers

Share price
₹724.20
Market cap
₹63,127 Cr
Revenue (annual)
₹4,643 Cr
Net profit (annual)
₹388.1 Cr
P/E (TTM)
134.1×Sector 54.5×
Promoter holding
53.79%+13.40% QoQ
FII holding
12.26%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Aster DM Quality Care Ltd

All →